Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma

Cisplatin is one of the most effective chemotherapeutic agents commonly used for several malignancies including oral squamous cell carcinoma (OSCC). Although cisplatin resistance is a major obstacle to effective treatment and is associated with poor prognosis of OSCC patients, the molecular mechanis...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Mol Sci
Päätekijät: Suenaga, Naoki, Kuramitsu, Mimi, Komure, Kanae, Kanemaru, Ayumi, Takano, Kanako, Ozeki, Kazuya, Nishimura, Yuka, Yoshida, Ryoji, Nakayama, Hideki, Shinriki, Satoru, Saito, Hideyuki, Jono, Hirofumi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6829433/
https://ncbi.nlm.nih.gov/pubmed/31635163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20205194
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia